Literature DB >> 22246664

Protective effect of Melothria maderaspatana leaf fraction on electrolytes, catecholamines, endothelial nitric oxide synthase and endothelin-1 peptide in uninephrectomized deoxycorticosterone acetate-salt hypertensive rats.

Chinnadurai Veeramani1, Khalid S Al-Numair, Govindasamy Chandramohan, Mohammed A Alsaif, Kodukkur Viswanathan Pugalendi.   

Abstract

This study was designed to investigate the protective effect of ethyl acetate fraction of Melothria maderaspatana (EAFM) leaf on electrolytes, catecholamines, endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) peptide in uninephrectomized deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Administration of DOCA-salt significantly increased the systolic and diastolic blood pressure and treatment with EAFM significantly lowered the blood pressure. In DOCA-salt rats, the levels of sodium and chloride increased significantly while potassium level decreased and administration of EAFM brought these parameters to normality. The levels of epinephrine and norepinephrine increased significantly in DOCA-salt rats and administration of EAFM significantly decreased these parameters to normality. DOCA-salt hypertensive rats exhibited significantly decreased L: -arginine and nitrite + nitrate levels and administration of EAFM brought these parameters to normality. DOA-salt hypertensive rats showed down-regulation of eNOS and up-regulation of ET-1 protein expressions in heart and kidney, and treatment with EAFM prevented down-regulation of eNOS and significantly down-regulated the ET-1 protein expressions. In conclusion, EAFM provides good blood pressure control by enhancing potassium and decreasing sodium levels, decreasing levels of epinephrine and norepinephrine, and preventing down-regulation of eNOS and significantly down-regulating ET-1 protein expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246664     DOI: 10.1007/s11418-011-0621-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  46 in total

1.  Prognostic significance of endothelial dysfunction in hypertensive patients.

Authors:  F Perticone; R Ceravolo; A Pujia; G Ventura; S Iacopino; A Scozzafava; A Ferraro; M Chello; P Mastroroberto; P Verdecchia; G Schillaci
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

Review 2.  The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.

Authors:  Toshio Ogihara; Masunori Matsuzaki; Hiroaki Matsuoka; Kazuaki Shimamoto; Kazuyuki Shimada; Hiromi Rakugi; Seiji Umemoto; Akira Kamiya; Norihiro Suzuki; Hiroo Kumagai; Yasuo Ohashi; Shuichi Takishita; Keishi Abe; Takao Saruta
Journal:  Hypertens Res       Date:  2005-04       Impact factor: 3.872

3.  Antihypertensive effect of Melothria maderaspatana leaf fractions on DOCA-salt-induced hypertensive rats and identification of compounds by GC-MS analysis.

Authors:  Chinnadurai Veeramani; Khalid S Al-Numair; Govindasamy Chandramohan; Mohammed A Alsaif; Adel A Alhamdan; Kodukkur Viswanathan Pugalendi
Journal:  J Nat Med       Date:  2011-10-01       Impact factor: 2.343

4.  Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats.

Authors:  Atsushi Suzuki; Daiji Kagawa; Akihiko Fujii; Ryuji Ochiai; Ichiro Tokimitsu; Ikuo Saito
Journal:  Am J Hypertens       Date:  2002-04       Impact factor: 2.689

5.  Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance.

Authors:  Y Kamada; H Nagaretani; S Tamura; T Ohama; T Maruyama; H Hiraoka; S Yamashita; A Yamada; S Kiso; Y Inui; N Ito; Y Kayanoki; S Kawata; Y Matsuzawa
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 6.  Role of endothelin in human hypertension.

Authors:  Rhian M Touyz; Ernesto L Schiffrin
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

7.  ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension.

Authors:  Glaucia E Callera; Rhian M Touyz; Simone A Teixeira; Marcelo N Muscara; Maria Helena C Carvalho; Zuleica B Fortes; Dorothy Nigro; Ernesto L Schiffrin; Rita C Tostes
Journal:  Hypertension       Date:  2003-08-11       Impact factor: 10.190

8.  Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats.

Authors:  M J Akpaffiong; A A Taylor
Journal:  Am J Hypertens       Date:  1998-12       Impact factor: 2.689

9.  The development of enzyme-linked immunosorbent assays (ELISA) for the catecholamines adrenalin and noradrenalin.

Authors:  J F Murphy; D H Davies; C J Smith
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

10.  Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.

Authors:  K Fujita; Y Matsumura; S Kita; Y Miyazaki; K Hisaki; M Takaoka; S Morimoto
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more
  1 in total

Review 1.  Anti-Hypertensive Herbs and Their Mechanisms of Action: Part II.

Authors:  M Akhtar Anwar; Sara S Al Disi; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-03-08       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.